Picture of ViroGates A/S logo

VIRO — ViroGates A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Virogates Raises FY Rev Guidance

BRIEF-Virogates Raises FY Rev Guidance

- ViroGates A/S VIROG.CO:

  • ANNOUNCED ON THURSDAY REVISED FINANCIAL GUIDANCE FOR 2026

  • NOW EXPECTS FULL-YEAR REVENUE BETWEEN DKK 6.5 AND 8 MILLION IN 2026

  • PREVIOUS GUIDANCE: REV OF DKK 6 TO 7 MILLION

  • MAINTAINS THE PREVIOUSLY GUIDED EBIT AT DKK -10 AND -12 MILLION

  • REV GUIDANCE HIKE DRIVEN BY VIROGATES’ U.S. COMMERCIAL PARTNER, SUPARBIOTM, TAKING DELIVERY OF MILESTONE ORDERS UNDER THE DISTRIBUTION AGREEMENT

Source text: ID:nMFN9QtYGJ

Further company coverage: VIROG.CO


(Gdansk Newsroom)

((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on ViroGates A/S

See all news